menu
    • menu

    Company profile for IRLAB

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Share this: We are dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). We strive to improve the future for patients who, today, lack effective treatment options. Research and development within CNS What distinguishes IRLAB’s research and development activities is, in particular, our unique proprieta...
    Share this: We are dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS). We strive to improve the future for patients who, today, lack effective treatment options. Research and development within CNS What distinguishes IRLAB’s research and development activities is, in particular, our unique proprietary research platform ISP – Integrative Screening Process. The platform enables discovery and development of therapeutic candidates for diseases related to the central nervous system (CNS).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IRLABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Arvid Wallgrens Backe 20 413 46 Gothenburg, Sweden
    Telephone
    Telephone
    +46(0)31 757 38 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://irlab.se/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/irlab-therapeutics-ab/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/IRLABThera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IRLAB Joins Redeye Tech & Life Science Day 2025
    IRLAB Joins Redeye Tech & Life Science Day 2025

    27 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-27/irlab-participates-in-redeye-technology-life-science-day-on-december-3-2025

    PHARMIWEB
    27 Nov 2025
    Share Share
    Irlab Appoints Nomination Committee For 2026 Agm
    Irlab Appoints Nomination Committee For 2026 Agm

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/nomination-committee-appointed-for-irlabs-annual-general-meeting-2026

    PHARMIWEB
    20 Nov 2025
    Share Share
    IRLAB Releases Interim Report For Jan-Sep 2025
    IRLAB Releases Interim Report For Jan-Sep 2025

    29 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-publishes-interim-report-for-the-period-january-september-2025-1093028

    ACCESSWIRE
    29 Oct 2025
    Share Share
    IRLAB: Invites To Q3 2025 Interim Report Presentation & Webcast
    IRLAB: Invites To Q3 2025 Interim Report Presentation & Webcast

    23 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-invitation-to-the-interim-report-for-q3-2025-presentation-and-w-1090990

    ACCESSWIRE
    23 Oct 2025
    Share Share
    IRLAB To Present At Redeye Theme: Neurology
    IRLAB To Present At Redeye Theme: Neurology

    09 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/irlab-to-present-at-redeye-theme-neurology-1084928

    ACCESSWIRE
    09 Oct 2025
    Share Share
    IRLAB Appoints Gustaf Albèrt As The New Chief Financial Officer
    IRLAB Appoints Gustaf Albèrt As The New Chief Financial Officer

    09 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-09/irlab-appoints-gustaf-albèrt-as-the-new-chief-financial-officer

    PHARMIWEB
    09 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search